ICU Medical Statistics
Total Valuation
ICU Medical has a market cap or net worth of $4.44 billion. The enterprise value is $5.29 billion.
| Market Cap | 4.44B |
| Enterprise Value | 5.29B |
Important Dates
The last earnings date was Thursday, November 5, 2026, after market close.
| Earnings Date | Nov 5, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
ICU Medical has 25.01 million shares outstanding. The number of shares has increased by 2.40% in one year.
| Current Share Class | 25.01M |
| Shares Outstanding | 25.01M |
| Shares Change (YoY) | +2.40% |
| Shares Change (QoQ) | +0.40% |
| Owned by Insiders (%) | 1.77% |
| Owned by Institutions (%) | 105.84% |
| Float | 24.56M |
Valuation Ratios
The trailing PE ratio is 74.13 and the forward PE ratio is 50.93. ICU Medical's PEG ratio is 4.54.
| PE Ratio | 74.13 |
| Forward PE | 50.93 |
| PS Ratio | 2.02 |
| Forward PS | 1.96 |
| PB Ratio | 1.96 |
| P/TBV Ratio | 25.65 |
| P/FCF Ratio | 21.17 |
| P/OCF Ratio | 15.82 |
| PEG Ratio | 4.54 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 14.02, with an EV/FCF ratio of 25.25.
| EV / Earnings | 87.29 |
| EV / Sales | 2.41 |
| EV / EBITDA | 14.02 |
| EV / EBIT | 30.01 |
| EV / FCF | 25.25 |
Financial Position
The company has a current ratio of 2.37, with a Debt / Equity ratio of 0.53.
| Current Ratio | 2.37 |
| Quick Ratio | 0.99 |
| Debt / Equity | 0.53 |
| Debt / EBITDA | 3.04 |
| Debt / FCF | 5.52 |
| Interest Coverage | 2.24 |
Financial Efficiency
Return on equity (ROE) is 2.79% and return on invested capital (ROIC) is 5.68%.
| Return on Equity (ROE) | 2.79% |
| Return on Assets (ROA) | 2.73% |
| Return on Invested Capital (ROIC) | 5.68% |
| Return on Capital Employed (ROCE) | 5.12% |
| Weighted Average Cost of Capital (WACC) | 8.32% |
| Revenue Per Employee | $167,927 |
| Profits Per Employee | $4,641 |
| Employee Count | 13,000 |
| Asset Turnover | 0.54 |
| Inventory Turnover | 2.12 |
Taxes
| Income Tax | -23.10M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +35.12% in the last 52 weeks. The beta is 0.88, so ICU Medical's price volatility has been lower than the market average.
| Beta (5Y) | 0.88 |
| 52-Week Price Change | +35.12% |
| 50-Day Moving Average | 162.91 |
| 200-Day Moving Average | 148.89 |
| Relative Strength Index (RSI) | 58.65 |
| Average Volume (20 Days) | 265,425 |
Short Selling Information
The latest short interest is 1.71 million, so 6.85% of the outstanding shares have been sold short.
| Short Interest | 1.71M |
| Short Previous Month | 1.52M |
| Short % of Shares Out | 6.85% |
| Short % of Float | 6.98% |
| Short Ratio (days to cover) | 6.84 |
Income Statement
In the last 12 months, ICU Medical had revenue of $2.18 billion and earned $60.33 million in profits. Earnings per share was $2.40.
| Revenue | 2.18B |
| Gross Profit | 879.02M |
| Operating Income | 175.49M |
| Pretax Income | 37.23M |
| Net Income | 60.33M |
| EBITDA | 375.55M |
| EBIT | 175.49M |
| Earnings Per Share (EPS) | $2.40 |
Balance Sheet
The company has $301.78 million in cash and $1.15 billion in debt, with a net cash position of -$850.07 million or -$33.99 per share.
| Cash & Cash Equivalents | 301.78M |
| Total Debt | 1.15B |
| Net Cash | -850.07M |
| Net Cash Per Share | -$33.99 |
| Equity (Book Value) | 2.19B |
| Book Value Per Share | 87.62 |
| Working Capital | 705.23M |
Cash Flow
In the last 12 months, operating cash flow was $279.24 million and capital expenditures -$70.65 million, giving a free cash flow of $208.60 million.
| Operating Cash Flow | 279.24M |
| Capital Expenditures | -70.65M |
| Depreciation & Amortization | 200.06M |
| Net Borrowing | -166.85M |
| Free Cash Flow | 208.60M |
| FCF Per Share | $8.34 |
Margins
Gross margin is 40.27%, with operating and profit margins of 8.04% and 2.76%.
| Gross Margin | 40.27% |
| Operating Margin | 8.04% |
| Pretax Margin | 1.71% |
| Profit Margin | 2.76% |
| EBITDA Margin | 17.20% |
| EBIT Margin | 8.04% |
| FCF Margin | 9.56% |
Dividends & Yields
ICU Medical does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -2.40% |
| Shareholder Yield | -2.40% |
| Earnings Yield | 1.35% |
| FCF Yield | 4.72% |
Analyst Forecast
The average price target for ICU Medical is $194.25, which is 9.34% higher than the current price. The consensus rating is "Buy".
| Price Target | $194.25 |
| Price Target Difference | 9.34% |
| Analyst Consensus | Buy |
| Analyst Count | 8 |
| Revenue Growth Forecast (3Y) | 2.32% |
| EPS Growth Forecast (3Y) | 10.45% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |
| Graham Formula Value | |
| Graham Formula Upside |
Stock Splits
The last stock split was on March 18, 2002. It was a forward split with a ratio of 1.5:1.
| Last Split Date | Mar 18, 2002 |
| Split Type | Forward |
| Split Ratio | 1.5:1 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 6 |